← FDA Drug Approvals (Drugs@FDA)

ABIRATERONE ACETATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MYLAN · Approved 2018-10-31

Drug application

FDA Application #

ANDA208446

Application type

Abbreviated New Drug Application (Generic)

Brand name

ABIRATERONE ACETATE

Generic name

ABIRATERONE ACETATE

Active ingredients

ABIRATERONE ACETATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MYLAN

Manufacturer

Mylan Pharmaceuticals Inc.

First approval

2018-10-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown